Skip to content
Biogenica

Molecular Testing

Molecular diagnostics that inform treatment decisions, not merely describe results: inherited risk, how patients metabolize medications, and pathogen identification with resistance markers.

BiogeneGx

Germline genetic testing.

CGx

Hereditary Cancer Genetics

Identifies patients at increased risk of cancer due to hereditary factors, so surveillance can start before disease does.

PGx

Pharmacogenetics

Reports how a patient's genotype affects their response to medication, with emphasis on pain, psychiatric and cardiovascular therapy.

PAD

Parkinson's, Alzheimer's and Dementia

Genetic markers associated with neurodegenerative disease, to support earlier and better-targeted treatment decisions.

BiogeneDx

Infectious disease identification by PCR.

RPP

Respiratory Pathogen Panel

Identifies the organism behind a respiratory infection, distinguishing viral from bacterial causes.

UTI

Urinary Tract Infection

Organism identification with antibiotic resistance markers, for cases culture leaves unresolved.

How results are reported.

Each gene is given with the diplotype found and the activity that follows from it, so a prescribing question can be answered from one table rather than assembled out of raw calls.

Specimen pharmacogenomic report: a genetic research summary listing genes, diplotypes and metaboliser activity
Specimen pharmacogenomic report. Patient details are illustrative. · Opens full size

Your ordering and results have not moved.

Requisitions, supply requests and patient results continue through the same system your practice already uses. This site is informational.

Clinical Results